As ACAP1 expression was strongly correlated with immune cytotoxicity activity and the infiltrating level of CD8+ T cells in tumors at a pan-cancer level, we wondered whether ACAP1 expression could predict the tumor response to ICT and the prognosis of ICT-treated patients. This evidence concerns the gene CD8A and neoplasm.